Share this job

Trainee (Public and Stakeholders Engagement)

Selection procedure reference: EMA/TR/1829 

Deadline for applications: 15 July 2020 23:59 CET 


The European Medicines Agency (EMA) is a decentralised agency of the European Union (EU), located in Amsterdam. It began operating in 1995. It is responsible for the scientific evaluation, supervision and safety monitoring of medicines in the EU.


The 2020 Traineeship programme is now open for applications until 15 July 2020 23:59 CET, with an intake on 1 October 2020.


1. About the traineeship programme

The Agency is looking for motivated, qualified recent graduates or students on an Erasmus+ or other programme or PhD students, who are interested in gaining experience and contribute to the Agency’s work for every patient in Europe. The purpose of a traineeship at the Agency is to perform tasks that are predominantly in the interest of the trainee’s training and principally serve to increase the trainee’s knowledge and to gain relevant experience.


Placement description

We are looking for a trainee to support the Public and Stakeholders Engagement department which is responsible for engagement with patients, healthcare professionals, and corporate stakeholders as well as Public information that EMA produces on medicines for these audiences.

Specific objectives and projects:

During your traineeship, you will participate and contribute to the following projects:

A. Driving collaborative evidence generation – improving the scientific quality of evaluations

  • Expand benefit-risk assessment and communication - Evaluate the impact and added value of patient involvement in Scientific Advisory Group (SAG) and Ad-hoc expert group meetings. Patients are invited to benefit-risk discussions to provide evidence based on their experience with a condition and its treatment. Results from the work will inform any future process improvement for future SAG/ad hoc expert groups. It is expected to deliver also a scientific publication demonstrating quantitative analysis and added value of patients.
  • Reinforce patient relevance in evidence generation - Support the establishment of focus groups in selected therapeutic areas. This new methodology is expected to support patient data collection on areas of unmet needs and to support the further development of patient-reported outcomes and quality of life, that will contribute to assessment of medicines and development of scientific guidelines.

B. Information on medicines for stakeholders

Important medicine-related information is prepared for the general public, such as medicine overviews and safety communications which are reviewed by patients and healthcare professionals prior to publication.

  • A pilot study is proposed using a new feedback form to reach out to patients involved in the review of medicine overviews. The feedback gathered will be analysed and used for improving the review process ensuring the feedback received is fit for purpose.
  • Review of the literature on best practices for user testing to assess new evidence that could be applicable. The aim is to ensure that information is generated in the most up to date fashion.
  • New impact assessment of EMA safety communications for patients and HCPs organisations and actions on optimising dissemination through the communication channels of these organisations
Learning outcomes:

We will help you to gain:

  • Understanding the methodology and value of engagement with EMA’s key stakeholders (patients, HCPs and general public) and the Agency’s approach to communication in key areas - such as vaccines- of technical information to the public and the value of engagement with key stakeholders.
  • Opportunity to interact with different EMA Divisions and departments and gain valuable insight building up experience from collaborations with various stakeholders.
Eligibility criteria

To be eligible for consideration for this placement, you are required to:

  1. enjoy full rights as a citizen of a European Union Member State or Iceland, Lichtenstein and Norway;
  2. possess a university degree in pharmacy, medicine, other life science, social science (minimum of three years or more) that must have been obtained within the last 12 months (July 2019 -July 2020) or be a university student on an Erasmus + or a similar programme or a PhD student.
  3. a thorough knowledge of English (at least level C1) and good knowledge of other official EU language (at least B2) of the Common European Framework for Languages

For criteria 1 and 2, you will be required to provide proof in the application form and at the interview stage. Failing to present these documents may result in the disqualification from the procedure.

Additional skills

In addition to the eligibility criteria, you will have:

  • Good written and spoken communication in English
  • Interest in type of information patients, healthcare professionals and the general public need.
  • Good editorial, grammatical and proof-reading skills
  • Good Excel skills desirable
Behavioural Competencies

You will demonstrate the following behavioural competencies:

  • Communication skills
  • Interpersonal skills
  • Working with others
  • Adaptability
  • Research and analytical skills
  • Learning and development
Selection timelines

Deadline for applications

15 July 2020 23:59 CET

Assessments (remote)

From 20 July 2020 to 15 August 2020

Decision expected

By 15 August 2020

 Placement start

1 October 2020

Conditions of traineeship

The traineeship is offered for 10 months (1 October 2020 – 31 July 2021) and takes place at the Agency’s premises in Amsterdam. Traineeships are offered for either full-time or part-time (80% or 50%) combined with university studies.

The Agency pays a monthly stipend of €1,360 for a full-time traineeship (reduced accordingly for 80% or 50%) and a travel contribution upon joining and leaving the Agency.

Each trainee will have a mentor at the Agency who will guide the trainee through the programme.

The conditions of employment are stated in the Executive Decision on rules governing the traineeship programme at the EMA available here.



Domenico Scarlattilaan 6 - 1083 HS Amsterdam - The Netherlands

Telephone +31 (0)88 781 6000 - Email recruitment@ema.europa.eu


© European Medicines Agency, 2020. Reproduction is authorised provided the source is acknowledged.